284 Tuberculosis and Hepatitis B Reactivation Are Rare After Treatment With Tumor Necrosis Factor Antagonist Therapy Among Patients With Inflammatory Bowel Disease.

Autor: Hou, Jason K., Kramer, Jennifer R., Richardson, Peter, Sansgiry, Shubhada, El-Serag, Hashem B.
Zdroj: Gastroenterology (00165085); Apr2015 Supplement 1, Vol. 148, pS-61-S-61, 1p
Databáze: Supplemental Index